Matches in Wikidata for { <http://www.wikidata.org/entity/Q83805331> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q83805331 description "clinical trial" @default.
- Q83805331 description "ensayu clínicu" @default.
- Q83805331 description "klinisch onderzoek" @default.
- Q83805331 description "клінічне випробування" @default.
- Q83805331 name "Pilot Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Abuse Liability of an Abuse-Deterrent Immediate-Release Formulation (ADAIR)" @default.
- Q83805331 name "Pilot Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Abuse Liability of an Abuse-Deterrent Immediate-Release Formulation (ADAIR)" @default.
- Q83805331 type Item @default.
- Q83805331 label "Pilot Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Abuse Liability of an Abuse-Deterrent Immediate-Release Formulation (ADAIR)" @default.
- Q83805331 label "Pilot Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Abuse Liability of an Abuse-Deterrent Immediate-Release Formulation (ADAIR)" @default.
- Q83805331 prefLabel "Pilot Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Abuse Liability of an Abuse-Deterrent Immediate-Release Formulation (ADAIR)" @default.
- Q83805331 prefLabel "Pilot Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Abuse Liability of an Abuse-Deterrent Immediate-Release Formulation (ADAIR)" @default.
- Q83805331 P1050 Q83805331-3C78AF27-6259-41E7-9387-7AA6DE093DBF @default.
- Q83805331 P1132 Q83805331-B6D8389E-2147-4CB5-944B-2E5102389226 @default.
- Q83805331 P1476 Q83805331-BE25BA07-D081-486A-B1DE-2C55843ADED1 @default.
- Q83805331 P17 Q83805331-0167296D-9233-4E9D-A669-3D9DD665CB69 @default.
- Q83805331 P2899 Q83805331-15A6F9C1-4057-4FCF-AAA4-6B1CA11E0F13 @default.
- Q83805331 P3098 Q83805331-EB4CC0BA-6651-4BBE-B57D-6E6AD75919F1 @default.
- Q83805331 P31 Q83805331-305B0DE9-C6CF-45F4-8372-509E22015A50 @default.
- Q83805331 P4135 Q83805331-936EE52C-5292-4FD3-8896-7977CB10D86F @default.
- Q83805331 P580 Q83805331-D47BCA9A-633F-4B96-A2C1-283CE1D5EB6F @default.
- Q83805331 P582 Q83805331-39018F08-1645-4C78-82F4-6C12FA49124D @default.
- Q83805331 P6099 Q83805331-7D938FC7-2E87-4B40-8359-54438344CB79 @default.
- Q83805331 P8363 Q83805331-EF68448A-0A6A-41B4-87AB-3F7107DAF0CC @default.
- Q83805331 P1050 Q189561 @default.
- Q83805331 P1132 "+16" @default.
- Q83805331 P1476 "A Pilot, Randomized, Double-Blind, Active-Controlled, 2-Treatment, Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Abuse Liability of Dextroamphetamine Sulfate From an Abuse-Deterrent Immediate-Release Formulation (ADAIR)" @default.
- Q83805331 P17 Q16 @default.
- Q83805331 P2899 "+18" @default.
- Q83805331 P3098 "NCT04232644" @default.
- Q83805331 P31 Q30612 @default.
- Q83805331 P4135 "+55" @default.
- Q83805331 P580 "2019-05-27T00:00:00Z" @default.
- Q83805331 P582 "2019-07-17T00:00:00Z" @default.
- Q83805331 P6099 Q5452194 @default.
- Q83805331 P8363 Q78089383 @default.